Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial.
Wu X, Senanayake R, Goodchild E, Bashari WA, Salsbury J, Cabrera CP, Argentesi G, O'Toole SM, Matson M, Koo B, Parvanta L, Hilliard N, Kosmoliaptsis V, Marker A, Berney DM, Tan W, Foo R, Mein CA, Wozniak E, Savage E, Sahdev A, Bird N, Laycock K, Boros I, Hader S, Warnes V, Gillett D, Dawnay A, Adeyeye E, Prete A, Taylor AE, Arlt W, Bhuva AN, Aigbirhio F, Manisty C, McIntosh A, McConnachie A, Cruickshank JK, Cheow H, Gurnell M, Drake WM, Brown MJ. Wu X, et al. Among authors: bird n. Nat Med. 2023 Jan;29(1):190-202. doi: 10.1038/s41591-022-02114-5. Epub 2023 Jan 16. Nat Med. 2023. PMID: 36646800 Free PMC article. Clinical Trial.
Development of a bespoke phantom to optimize molecular PET imaging of pituitary tumors.
Gillett D, Marsden D, Crawford R, Ballout S, MacFarlane J, van der Meulen M, Gillett B, Bird N, Heard S, Powlson AS, Santarius T, Mannion R, Kolias A, Harper I, Mendichovszky IA, Aloj L, Cheow H, Bashari W, Koulouri O, Gurnell M. Gillett D, et al. Among authors: bird n. EJNMMI Phys. 2023 Jun 1;10(1):34. doi: 10.1186/s40658-023-00552-9. EJNMMI Phys. 2023. PMID: 37261547 Free PMC article.
Changing incentives to ACCELERATE drug development for paediatric cancer.
de Rojas T, Kearns P, Blanc P, Skolnik J, Fox E, Knox L, Rousseau R, Doz F, Bird N, Pearson AJ, Vassal G. de Rojas T, et al. Among authors: bird n. Cancer Med. 2023 Apr;12(7):8825-8837. doi: 10.1002/cam4.5627. Epub 2023 Jan 16. Cancer Med. 2023. PMID: 36645217 Free PMC article.
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
Rossig C, Pearson AD, Vassal G, Scobie N, Bird N, Blanc P, Vormoor HJ, Calkoen FG, Locatelli F, Del Bufalo F, Rives S, Jacoby E, Balduzzi A, Bourquin JP, Baruchel A. Rossig C, et al. Among authors: bird n. J Clin Oncol. 2024 Jan 20;42(3):253-257. doi: 10.1200/JCO.23.01314. Epub 2023 Nov 27. J Clin Oncol. 2024. PMID: 38011605 No abstract available.
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.
Moreno L, DuBois SG, Glade Bender J, Mauguen A, Bird N, Buenger V, Casanova M, Doz F, Fox E, Gore L, Hawkins DS, Izraeli S, Jones DTW, Kearns PR, Molenaar JJ, Nysom K, Pfister S, Reaman G, Smith M, Weigel B, Vassal G, Zwaan CM, Paoletti X, Iasonos A, Pearson ADJ. Moreno L, et al. Among authors: bird n. J Clin Oncol. 2023 Jun 20;41(18):3408-3422. doi: 10.1200/JCO.22.02430. Epub 2023 Apr 4. J Clin Oncol. 2023. PMID: 37015036 Free PMC article. Review.
Dense sampling of ethnic groups within African countries reveals fine-scale genetic structure and extensive historical admixture.
Bird N, Ormond L, Awah P, Caldwell EF, Connell B, Elamin M, Fadlelmola FM, Matthew Fomine FL, López S, MacEachern S, Moñino Y, Morris S, Näsänen-Gilmore P, Nketsia V NK, Veeramah K, Weale ME, Zeitlyn D, Thomas MG, Bradman N, Hellenthal G. Bird N, et al. Sci Adv. 2023 Mar 29;9(13):eabq2616. doi: 10.1126/sciadv.abq2616. Epub 2023 Mar 29. Sci Adv. 2023. PMID: 36989356 Free PMC article.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, Dorward J, Lowe DM, Standing JF, Breuer J, Khoo S, Petrou S, Hood K, Nguyen-Van-Tam JS, Patel MG, Saville BR, Marion J, Ogburn E, Allen J, Rutter H, Francis N, Thomas NPB, Evans P, Dobson M, Madden TA, Holmes J, Harris V, Png ME, Lown M, van Hecke O, Detry MA, Saunders CT, Fitzgerald M, Berry NS, Mwandigha L, Galal U, Mort S, Jani BD, Hart ND, Ahmed H, Butler D, McKenna M, Chalk J, Lavallee L, Hadley E, Cureton L, Benysek M, Andersson M, Coates M, Barrett S, Bateman C, Davies JC, Raymundo-Wood I, Ustianowski A, Carson-Stevens A, Yu LM, Little P; PANORAMIC Trial Collaborative Group. Butler CC, et al. Lancet. 2023 Jan 28;401(10373):281-293. doi: 10.1016/S0140-6736(22)02597-1. Epub 2022 Dec 22. Lancet. 2023. PMID: 36566761 Free PMC article. Clinical Trial.
Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.
Sriranjan R, Zhao TX, Tarkin J, Hubsch A, Helmy J, Vamvaka E, Jalaludeen N, Bond S, Hoole SP, Knott P, Buckenham S, Warnes V, Bird N, Cheow H, Templin H, Cacciottolo P, Rudd JHF, Mallat Z, Cheriyan J. Sriranjan R, et al. Among authors: bird n. BMJ Open. 2022 Oct 7;12(10):e062602. doi: 10.1136/bmjopen-2022-062602. BMJ Open. 2022. PMID: 36207050 Free PMC article.
233 results